Skip to main content
. 2023 Nov 29;18(11):e0250909. doi: 10.1371/journal.pone.0250909

Table 1. Results of meta-regression to explore the source of heterogeneity.

No of studies Heterogeneity (I2) Amount of heterogeneity accounted for (R2) (%)
Follow-up period Age Gender (male)
Pain-related symptoms
Chest pain 17 99 0 0 0
Headache 21 99 0 0 0
Arthralgia 13 99 0 0 0
Neuralgia 3 97 100 (+) 92 (-) 69 (+)
Abdominal pain 10 98 0 0 0
Myalgia 18 100 0 0 0
Sore throat 17 99 0 0 0
Ear pain 4 99 0 0 0
Other symptoms
Fatigue 28 99 0 0 0
Insomnia 7 100 44 (+) 28 (-) 75 (+)
Dyspnea 23 99 34 (+) 0 0
Weakness 5 98 0 64 (-) 0
Anosmia 24 99 0 35 (-) 0
Cough 23 99 0 42 (-) 10 (-)
Ageusia 19 99 0 0 19 (-)
Memory impairment 9 98 73 (+) 5 (+) 40 (+)
Confusion 5 94 0 0 0
Depression 10 99 55 (-) 0 23 (+)
Fever 17 99 0 0 0
Rhinorrhea 8 98 0 0 0
Anxiety 8 99 66 (+) 0 67 (+)
Palpitation 8 100 0 0 0
Sneezing 3 99 0 0 0
Alopecia 6 96 0 0 0
Anorexia 9 99 0 0 0
Nasal blockage 4 74 33 (-) 0 70 (+)
Diarrhea 19 99 0 0 0
Vertigo (Dizziness) 13 99 0 0 0
Weight loss 13 93 23 (-) 0 40 (+)
Sputum 6 50 65 (-) 0 0
Chills 6 99 72 (+) 0 77 (+)
Nausea 11 99 54 (+) 1 (-) 0
Vomiting 6 91 7 (+) 0 0

R2 represents a measure of the amount of heterogeneity that can be explained by the covariate. Bold numbers indicate that a significant correlation was found between the symptom and the covariate. + or–in parenthesis indicates a positive or negative coefficient in the regression model. Note that for insomnia and follow-up period, for instance, the incidence of insomnia is significantly higher when the follow-up period increases (positive correlation). Note that for ageusia and sex, the incidence of ageusia is significantly higher when the ratio of males in a study population decreases (inverse correlation).